SCHEMBL30455685

SCHEMBL30455685

[2H]c1ccc2[nH]c3c(c2c1)CCCC3N[C@H](C)c1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 2/20 0.69
▸ KCNH2 Q12809 1/20 0.69
▸ RB1 P06400 7/20 0.51
▸ BRD3 Q15059 3/20 0.44
▸ CDC42 P60953 1/20 0.41
▸ SIRT2 Q8IXJ6 1/20 0.40
▸ SIRT1 Q96EB6 1/20 0.40
▸ GAA P10253 2/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ CASP6 P55212 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ GLA P06280 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25247033 0.92 CYP2D6 (0.76) CYP2D6KCNH2RB1BRD3CDC42
SCHEMBL4196180 0.92 CYP2D6 (0.76) CYP2D6KCNH2RB1BRD3CDC42
SCHEMBL30455215 0.92 CYP2D6 (0.76) CYP2D6KCNH2RB1BRD3CDC42
SCHEMBL25287616 0.92 CYP2D6 (0.76) CYP2D6KCNH2RB1BRD3CDC42
Hydrochloric Acid SCHEMBL4158280 0.91 CYP2D6 (0.74) CYP2D6KCNH2RB1BRD3CDC42
SCHEMBL25286477 0.83 CYP2D6 (0.64) CYP2D6KCNH2RB1BRD3CDC42
SCHEMBL25249451 0.83 CYP2D6 (0.64) CYP2D6KCNH2RB1BRD3SIRT2
SCHEMBL25285965 0.83 CYP2D6 (0.64) CYP2D6KCNH2RB1BRD3SIRT2
SCHEMBL25286478 0.83 CYP2D6 (0.64) CYP2D6KCNH2RB1BRD3CDC42
SCHEMBL20537339 0.82 CYP2D6 (0.78) CYP2D6KCNH2RB1BRD3CDC42

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023121238-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME (주)메디픽 2023-06-29 — — WO disclosed
Send feedback